Lupin and SunPharma Launch Generic Favipiravir to Treat Mild to Moderate COVID-19 in India
Shots:
- Lupin has launched favipiravir in India under the brand name ‘Covihalt’ for the treatment of mild to moderate COVID-19
- Covihalt will be available as 200mg tablets in the form of a strip of 10 tablets- priced at $0.65 (₹49/tablet) and has received DCGI authorization for emergency use
- Additionally- SunPharma has launched antiviral drug favipiravir under the brand name 'FluGuard' to treat mild to moderate cases of COVID-19- at ₹35/tablet in India
Lupin- SunPharma | Image: StraitTimes
Click here to read the full press release
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com